May 08
CB Scientific, Inc. is now Cardiac Biotech Solutions, Inc., reflecting our mission to deliver advanced, cloud-connected cardiac monitoring technologies across global healthcare markets.
Feb 25
CB Scientific, Inc. (CBSC) has officially launched its next-generation MyCardia AT cardiac event monitor in collaboration with Datrix, LLC. Designed for enhanced remote cardiac monitoring, the FDA-cleared device offers a lightweight, easy-to-use design with seamless integration into the MyCardia app ecosystem. The MyCardia AT monitor enables early detection of cardiac arrhythmias, helping physicians diagnose transient heart conditions more effectively. The device is set to roll out across SE Asia, Hong Kong, Macau, and pending regulatory approvals, Canada and China.
Mar 09
Your Heart Protector Corp. to market the Company’s products and provide associated monitoring services throughout Canada
Sep 06
Updated product to include significant operating improvements and material design advances over the current offering
Dec 07
Partnership to provide high-volume manufacturing capability and facilitate obtaining requisite government approvals.
Oct 08
Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd. to begin exclusive distribution of CB Scientific’s FDA & CE-cleared EKG products to an expansive private and government hospital network.
Sep 22
An experienced executive management team is leading the way in the FDA and CE-cleared cardiac monitoring products and services arena, using smart phones and cloud-based software technology.
